Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral ImmunotherapyCompany founded by 4BIO Capital and ...

The company's proprietary Synthetic Super-Enhancers (SSEs) are engineered DNA elements that act as docking stations for transcription factors uniquely expressed in aggressive cancer cells. This ...

They also found that two signaling molecules, or cytokines, called IL2 and IL10 were required for expression of BLIMP1. "IL10 ...

Researchers developed a barcoded directed evolution system for engineered virus-like particles (eVLPs), creating a ...